Estrogen Replacement Therapy

"Estrogen Replacement Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.

Descriptor ID	D015914
MeSH Number(s)	E02.319.452.150
Concept/Terms	Estrogen Replacement Therapy Estrogen Replacement Therapy Estrogen Replacement Therapies Replacement Therapies, Estrogen Therapies, Estrogen Replacement Therapy, Estrogen Replacement Replacement Therapy, Estrogen Estrogen Replacement Estrogen Replacement Estrogen Replacements Replacements, Estrogen Replacement, Estrogen Postmenopausal Hormone Replacement Therapy Postmenopausal Hormone Replacement Therapy Hormone Replacement Therapy, Post-Menopausal Hormone Replacement Therapy, Post Menopausal Estrogen Progestin Replacement Therapy Estrogen Progestin Replacement Therapy Estrogen Progestin Combination Therapy

Below are MeSH descriptors whose meaning is more general than "Estrogen Replacement Therapy".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Hormone Replacement Therapy [E02.319.452]
Estrogen Replacement Therapy [E02.319.452.150]

Below are MeSH descriptors whose meaning is related to "Estrogen Replacement Therapy".

Below are MeSH descriptors whose meaning is more specific than "Estrogen Replacement Therapy".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Estrogen Replacement Therapy" by people in this website by year, and whether "Estrogen Replacement Therapy" was a major or minor topic of these publications.

Bar chart showing 6 publications over 5 distinct years, with a maximum of 2 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2011	0	1	1
2013	1	1	2
2015	0	1	1
2018	1	0	1
2020	0	1	1

Below are the most recent publications written about "Estrogen Replacement Therapy" by people in Profiles.

Haring B, Liu J, Rapp SR, Shimbo D, Padula CB, Mozhui K, Li W, Espeland M, Wassertheil-Smoller S. Heart Rate, Brain Imaging Biomarkers and Cognitive Impairment in Older (=63 years) Women. Am J Cardiol. 2020 08 15; 129:102-108.

View in: PubMed
Crawford SL, Crandall CJ, Derby CA, El Khoudary SR, Waetjen LE, Fischer M, Joffe H. Menopausal hormone therapy trends before versus after 2002: impact of the Women's Health Initiative Study Results. Menopause. 2018 12 21; 26(6):588-597.

View in: PubMed
Keaney JF, Solomon CG. Postmenopausal Hormone Therapy and Atherosclerosis--Time Is of the Essence. N Engl J Med. 2016 Mar 31; 374(13):1279-80.

View in: PubMed
Crandall CJ, Hovey KM, Andrews CA, Cauley JA, Manson JE, Wactawski-Wende J, Wright NC, Li W, Beavers K, Curtis JR, LeBoff MS. Bone Mineral Density as a Predictor of Subsequent Wrist Fractures: Findings From the Women's Health Initiative Study. J Clin Endocrinol Metab. 2015 Nov; 100(11):4315-24.

View in: PubMed
Ma Y, H?bert JR, Balasubramanian R, Wedick NM, Howard BV, Rosal MC, Liu S, Bird CE, Olendzki BC, Ockene JK, Wactawski-Wende J, Phillips LS, Lamonte MJ, Schneider KL, Garcia L, Ockene IS, Merriam PA, Sepavich DM, Mackey RH, Johnson KC, Manson JE. All-cause, cardiovascular, and cancer mortality rates in postmenopausal white, black, Hispanic, and Asian women with and without diabetes in the United States: the Women's Health Initiative, 1993-2009. Am J Epidemiol. 2013 Nov 15; 178(10):1533-41.

View in: PubMed
Espeland MA, Shumaker SA, Leng I, Manson JE, Brown CM, LeBlanc ES, Vaughan L, Robinson J, Rapp SR, Goveas JS, Wactawski-Wende J, Stefanick ML, Li W, Resnick SM. Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years. JAMA Intern Med. 2013 Aug 12; 173(15):1429-36.

View in: PubMed
D?ez-P?rez A, Hooven FH, Adachi JD, Adami S, Anderson FA, Boonen S, Chapurlat R, Compston JE, Cooper C, Delmas P, Greenspan SL, Lacroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, Roux C, Saag KG, Sambrook P, Silverman S, Siris ES, Watts NB, Nika G, Gehlbach SH. Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone. 2011 Sep; 49(3):493-8.

View in: PubMed
Norman SA, Weber AL, Localio AR, Marchbanks PA, Ursin G, Strom BL, Weiss LK, Burkman RT, Bernstein L, Deapen DM, Folger SG, Simon MS, Nadel MR. Hormone therapy and fatal breast cancer. Pharmacoepidemiol Drug Saf. 2010 May; 19(5):440-7.

View in: PubMed
Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB. Incidence and mortality of hip fractures in the United States. JAMA. 2009 Oct 14; 302(14):1573-9.

View in: PubMed
Saver BG, Gustafson D, Taylor TR, Hawkins RP, Woods NF, Dinauer S, Casey S, MacLaren-Loranger A. A tale of two studies: the importance of setting, subjects and context in two randomized, controlled trials of a web-based decision support for perimenopausal and postmenopausal health decisions. Patient Educ Couns. 2007 May; 66(2):211-22.

View in: PubMed

People

Explore

Similar Concepts

Top Journals